Bulletin, Institute

The JumpStart Grant for California

CLSI is urging CLSA Fellows to take advantage of a valuable offering from Pharma Directions. The JumpStart Grant provides the winning company with a comprehensive development plan that includes a strategic plan, GANTT chart with milestones, critical path and itemized budget that can be used to raise funds and execute your path to IND (an estimated value of $25,000). Applicant companies should be privately-held therapeutic (small molecule or biologics) company, must be located in California, and be a member of CLSA and/or BioCom.

The Award

Each grant recipient will receive a product development plan and a commercial plan consisting of the following.

  • Description of CMC activities required to support the toxicology program and first-in-human clinical study
  • Discussion of the proposed nonclinical program to support the intended indication, including justification
  • Overall regulatory strategy
  • High-level synopsis of the first-in-human clinical study
  • A detailed development plan budget including selection of clinical CRO (approximate timeline and budget for clinical plan)

All applications MUST be submitted by midnight on September 16, 2016.  Award recipients will be announced December 2016.  For more information, please visit: